Skip to main content
Have a personal or library account? Click to login
Dual effect of the GHRL gene variant in the molecular pathogenesis of obesity Cover

Dual effect of the GHRL gene variant in the molecular pathogenesis of obesity

By:  and    
Open Access
|Jul 2021

Figures & Tables

Table 1

Details of polymerase chain reaction primers and restriction endonucleases used, and of the resulting restriction fragments.

GHRL PolymorphismPCR Primers (5’>3’)Restriction EnzymeDigestion PatternRef.
rs34911341 (Arg51Gln)F: TCC AGC CTG CCA CTT AGC
R: GGA CCC TGT TC ACT GCC AC
SacIC allele: 373 bp; T allele: 210 and 163 bp[28]
rs696217 (Leu72Met)F: TCC AGC CTG CCA CTT AGC
R: GGA CCC TGT TC ACT GCC AC
BsrIG allele: 373 bp; T allele: 271 and 101 bp[28]

[i] PCR: polymerase chain reaction; F: forward; R: reverse.

Table 2

Baseline characteristics of the studied population.

ParametersObese Subjects (n=106)Non Obese Subjects (n=95)p Value
Age (years)41.56±9.8739.03±9.450.066
BMI (kg/m2)41.58±4.9322.61±1.82<0.0001
Waist circumference (cm)112.40±13.1385.50±7.33<0.0001
Hip circumference (cm)120.50±12.5799.10±6.14<0.0001
Fasting glucose (mg/dL)102.5±23.4689.60±7.35<0.0001
Total cholesterol (mg/dL)231.30±38.17203.90±35.57<0.0001
LDL-C (mg/dL)144.30±33.42125.70±30.29<0.0001
HDL-C (mg/dL)47.40±10.5554.80±9.36<0.0001
Triglycerides (mg/dL)163.10±85.11102.20±41.22<0.0001
HOMA-IR4.60±4.012.20±1.13<0.0001

[i] BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol,

HOMA-IR: homeostatis model assessment of insulin resistance.

Table 3

The genotype distribution and the allele frequencies of the GHRL gene variants. [Results are presented as n (%)]

A) GenotypeObese Subjects (n=106)Non Obese Subjects (n=95)p Value
rs34911341 (C>T) (Arg51Gln)
CC104 (98.12)95 (100.00)0.40
CT1 (0.94)0 (0.00)
TT1 (0.94)0 (0.00)
rs696217 (G>T) (Leu72Met)
GG37 (34.91)57 (60.00)0.0012
GT57 (53.77)34 (35.79)
TT12 (11.32)4 (4.21)
B) Allele FrequencyObese Subjects (n=106)Non Obese Subjects (n=95)p Value
rs34911341 (C>T) (Arg51Gln)
C209 (98.58)190 (100.00)0.25
T3 (1.42)0 (0.00)
rs696217 (G>T) (Leu72Met)
G131 (61.79)148 (77.79)0.0005
T81 (38.21)42 (22.11)
Table 4

Anthropometric and metabolic characteristics of all subjects in the genotypes of the rs696217 (G>T) polymorphism. [Data are expressed as mean±SD. Analysis of variance (ANOVA) was performed for comparison of the subgroups; bold p values are significant.]

ParametersGG (n=94)GT (n=91)TT (n=16)p Value
Age (years)40.17±8.4840.30±11.1341.88±8.430.8
BMI (kg/m2)34.00±24.4831.30±8.6833.13±9.440.81
Waist circumference (cm)95.61±15.70a102.90±17.43105.50±20.830.005
Hip circumference (cm)106.70±13.87b,c113.10±14.08116.60±17.230.002
Fasting glucose (mg/dL)93.83±12.7597.62±17.88105.20±41.120.06
Total cholesterol (mg/dL)221.00±34.66212.90±43.36233.40±44.090.104
LDL-C (mg/dL)134.5.0±29.26134.30±35.43148.50±41.230.266
HDL-C (mg/dL)52.94±10.6148.62±10.56d52.25±9.160.018
Triglycerides (mg/dL)129.00±64.40137.80±80.77145.80±92.200.59
HOMA-IR3502.00±2.203246.00±2.404522.00±3.900.34

[i] BMI: ment body of insulin mass resistance. index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol, HOMA-IR: homeostatis model assess-

a Significant difference between GG genotype and GT genotype by post-hoc Tukey test (p = 0.0104).

b Significant difference between GG genotype and GT genotype by post-hoc Tukey test (p = 0.0068).

c Significant difference between GG genotype and TT genotype by post-hoc Tukey test (p = 0.028).

d Significant difference between GG genotype and GT genotype by post-hoc Tukey test (p = 0.015).

DOI: https://doi.org/10.2478/bjmg-2021-0011 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 27 - 34
Published on: Jul 27, 2021
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2021 E Becer, MC Ergoren, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.